Research Article
Safety and Efficacy of Triple Antithrombotic Therapy with Dabigatran versus Vitamin K Antagonist in Atrial Fibrillation Patients: A Pilot Study
Figure 3
Kaplan-Meier cumulative probability of hospitalization event-free survival in recipients of dabigatran (DAB) and vitamin K antagonist (VKA) treatment.